Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-118747
Filing Date
2025-12-05
Accepted
2025-12-05 16:30:22
Documents
1
Period of Report
2025-12-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0268692-6k_xtlbio.htm 6-K 12107
  Complete submission text file 0001213900-25-118747.txt   13158
Mailing Address 26 BEN-GURION ST. RAMAT GAN L3 5112001
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 251553396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)